Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia

Male lower urinary tract symptoms (LUTS) is an increasingly important problem for the majority of late middle aged and elderly men. Fexapotide triflutate (FT) is a first in-class compound given by local injection via the transrectal intraprostatic route under ultrasound guidance. Data from >1700...

Descripción completa

Detalles Bibliográficos
Autores principales: Shore, Neal, Tutrone, Ronald, Roehrborn, Claus G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348527/
https://www.ncbi.nlm.nih.gov/pubmed/30719081
http://dx.doi.org/10.1177/1756287218820807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348527/
https://www.ncbi.nlm.nih.gov/pubmed/30719081
http://dx.doi.org/10.1177/1756287218820807

Ejemplares similares